The underlying genetic defect of primary hyperoxaluria type 1 (PH1)—mutation of the AXGT gene encoding enzyme alanine-glyoxylate aminotransferase—leads to systemic accumulation of oxalate deposits in many tissues, except the liver, where the enzyme is localized. The gene discussed is AGXT; the disease is primary hyperoxaluria type 1.